Hsa-miR-141-3p Downregulates ZBTB16 Expression in Cervical Cancer Tissue and Cells
Researchers found that hsa-miR-141-3p is upregulated in cervical cancer and directly suppresses ZBTB16 expression at the cellular level.
Researchers found that hsa-miR-141-3p is upregulated in cervical cancer and directly suppresses ZBTB16 expression at the cellular level.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.